Eriocip (Erlotinib) 150 mg is a targeted prescription medication used to treat metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer. Manufactured by Cipla, it acts …
Eriocip (Erlotinib) 150 mg is a targeted prescription medication used to treat metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer. Manufactured by Cipla, it acts as an epidermal growth factor receptor (EGFR) inhibitor to slow the growth and spread of cancer cells.
liketo,usa.uk.china.southkorea.russia.japan.singapore
Strength 150 mg
Dose/Strength 150 mg
Company Cipla
Usage Lung cancer
Brand Erlocip
Shelf Life 24 months
Form Tablet
Manufacturer Cipla Ltd
Country of Origin Made in India
Pack Size 30 Tablets
Therapeutic Uses Pharmacy dropshipper
Composition Erlotinib Tablets IP
Minimum order quantity: 50 Bottle
Composition details not available.
We offer reliable delivery across India and international markets. Domestic orders typically arrive within 5–7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity and quality.
